Follow this preprint
Decoding the impact of fibroblast heterogeneity on prognosis and drug resistance in high-grade serous ovarian cancer through tumor evolution analysis
Tingjie Wang, Lingxi Tian, Bing Wei, Jun Li, Cuiyun Zhang, Ruitao Long, Xiaofei Zhu, Yougai Zhang, Bo Wang, Jun Yang, Yongjun Guo
doi: https://doi.org/10.1101/2024.06.11.24308797
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Tingjie Wang
1Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
2Henan Key Laboratory of Molecular Pathology, Zhengzhou, China
Lingxi Tian
3MOE Key Laboratory of Intelligent Biomanufacturing, School of Bioengineering, Dalian University of Technology, Dalian 116024, PR China
Bing Wei
1Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
2Henan Key Laboratory of Molecular Pathology, Zhengzhou, China
Jun Li
1Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
2Henan Key Laboratory of Molecular Pathology, Zhengzhou, China
Cuiyun Zhang
1Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
2Henan Key Laboratory of Molecular Pathology, Zhengzhou, China
Ruitao Long
5School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Xiaofei Zhu
4Department of clinical laboratory, the third affiliated hospital of Xinxiang Medical University,
6Henan Key Laboratory of Immunology and Targeted Drugs, Xinxiang Key Laboratory of Tumor Microenvironment and Immunotherapy, School of Medical Technology, Xinxiang Medical University
Yougai Zhang
1Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
2Henan Key Laboratory of Molecular Pathology, Zhengzhou, China
Bo Wang
1Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
2Henan Key Laboratory of Molecular Pathology, Zhengzhou, China
Jun Yang
3MOE Key Laboratory of Intelligent Biomanufacturing, School of Bioengineering, Dalian University of Technology, Dalian 116024, PR China
Yongjun Guo
1Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
2Henan Key Laboratory of Molecular Pathology, Zhengzhou, China

Posted June 12, 2024.
Decoding the impact of fibroblast heterogeneity on prognosis and drug resistance in high-grade serous ovarian cancer through tumor evolution analysis
Tingjie Wang, Lingxi Tian, Bing Wei, Jun Li, Cuiyun Zhang, Ruitao Long, Xiaofei Zhu, Yougai Zhang, Bo Wang, Jun Yang, Yongjun Guo
medRxiv 2024.06.11.24308797; doi: https://doi.org/10.1101/2024.06.11.24308797
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (414)
- Allergy and Immunology (735)
- Anesthesia (216)
- Cardiovascular Medicine (3150)
- Dermatology (267)
- Emergency Medicine (467)
- Epidemiology (13115)
- Forensic Medicine (15)
- Gastroenterology (875)
- Genetic and Genomic Medicine (4938)
- Geriatric Medicine (455)
- Health Economics (758)
- Health Informatics (3109)
- Health Policy (1110)
- Hematology (414)
- HIV/AIDS (981)
- Medical Education (460)
- Medical Ethics (121)
- Nephrology (508)
- Neurology (4693)
- Nursing (249)
- Nutrition (695)
- Oncology (2421)
- Ophthalmology (689)
- Orthopedics (270)
- Otolaryngology (334)
- Pain Medicine (313)
- Palliative Medicine (88)
- Pathology (523)
- Pediatrics (1258)
- Primary Care Research (530)
- Public and Global Health (7258)
- Radiology and Imaging (1623)
- Respiratory Medicine (950)
- Rheumatology (463)
- Sports Medicine (408)
- Surgery (524)
- Toxicology (65)
- Transplantation (223)
- Urology (193)